India, June 17 -- Cosmos Health Inc. (COSM), an integrated healthcare company, on Wednesday announced entering a five-year contract manufacturing agreement with Pharmex S.A. via its wholly owned subsidiary Cana Laboratories.
The company has agreed to manufacture three pharmaceutical products at Cana's EU-GMP-licensed, EMA-certified facility. The combined output over the five-year term is estimated to be 2.86 million units. The individual products and quantities are as follows:
i) BETAFUSIN - a pharmaceutical cream of betamethasone and fusidic acid. The company is slated to manufacture 450,000 units a year, or 2,250,000 units over five years.
ii) BOTAFEX- a cutaneous solution of Minoxidil. The company expects to manufacture 65,000 units a...